Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  61,018 results for ""Drug Resistance, Neoplasm""

Your Filters

Language : english Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Hsa_circ_0096157 silencing suppresses autophagy and reduces cisplatin resistance in non-small cell lung cancer by weakening the Nrf2/ARE signaling pathway.

  • Authors : Lu H; Department of Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, 530021, People's Republic of China.; Kong J

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/pharmacology ; NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/metabolism ; NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/genetics

  • Source: Molecular biology reports [Mol Biol Rep] 2024 Jun 01; Vol. 51 (1), pp. 703. Date of Electronic Publication: 2024 Jun 01.Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978

Record details

Read More Add to Saved list
×
Academic Journal

INHBA regulates Hippo signaling to confer 5-FU chemoresistance mediated by cellular senescence in colon cancer cells.

  • Authors : Zhang Z; Department of Hematology and Oncology, Taizhou First People's Hospital, Taizhou 318020, China; Huangyan Hospital of Wenzhou Medical University, Taizhou 318020, China.

Subjects: Fluorouracil*/Fluorouracil*/Fluorouracil*/pharmacology ; Cellular Senescence*/Cellular Senescence*/Cellular Senescence*/drug effects ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/pathology

  • Source: The international journal of biochemistry & cell biology [Int J Biochem Cell Biol] 2024 Jun; Vol. 171, pp. 106570. Date of Electronic Publication: 2024 Apr 07.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9508482 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SNHG4-mediated PTEN destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis.

  • Authors : Li SQ; Department of Research, Guangxi Medical University Cancer Hospital, No. 71 Hedi Road, Nanning, 530021, Guangxi, China.; Xu WT

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology

  • Source: Apoptosis : an international journal on programmed cell death [Apoptosis] 2024 Jun; Vol. 29 (5-6), pp. 835-848. Date of Electronic Publication: 2024 Apr 04.Publisher: Springer Country of Publication: Netherlands NLM ID: 9712129 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling.

  • Authors : Ciccone V; Department of Life Sciences, University of Siena, Siena I-53100, Italy.; Simonis V

Subjects: Melanoma*/Melanoma*/Melanoma*/drug therapy ; Melanoma*/Melanoma*/Melanoma*/pathology ; Melanoma*/Melanoma*/Melanoma*/metabolism

  • Source: Biochemical pharmacology [Biochem Pharmacol] 2024 Jun; Vol. 224, pp. 116252. Date of Electronic Publication: 2024 May 01.Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

PYCR3 modulates mtDNA copy number to drive proliferation and doxorubicin resistance in triple-negative breast cancer.

  • Authors : Zhuang F; Department of Medical Oncology, Yantaishan Hospital, Yantai, Shandong, China.; Huang S

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy

  • Source: The international journal of biochemistry & cell biology [Int J Biochem Cell Biol] 2024 Jun; Vol. 171, pp. 106581. Date of Electronic Publication: 2024 Apr 19.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9508482 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Glucocorticoids paradoxically promote steroid resistance in B cell acute lymphoblastic leukemia through CXCR4/PLC signaling.

  • Authors : Abdoul-Azize S; Univ Rouen Normandie, Inserm, UMR 1234, F-76000, Rouen, France. .; Hami R

Subjects: Receptors, CXCR4*/Receptors, CXCR4*/Receptors, CXCR4*/metabolism ; Receptors, CXCR4*/Receptors, CXCR4*/Receptors, CXCR4*/genetics ; Signal Transduction*/Signal Transduction*/Signal Transduction*/drug effects

  • Source: Nature communications [Nat Commun] 2024 May 29; Vol. 15 (1), pp. 4557. Date of Electronic Publication: 2024 May 29.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Targeting ARNT attenuates chemoresistance through destabilizing p38α-MAPK signaling in glioblastoma.

  • Authors : Alafate W; Department of Neurosurgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. .; Lv G

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Glioblastoma*/Glioblastoma*/Glioblastoma*/metabolism

  • Source: Cell death & disease [Cell Death Dis] 2024 May 28; Vol. 15 (5), pp. 366. Date of Electronic Publication: 2024 May 28.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Multiplexed single-cell lineage tracing of mitotic kinesin inhibitor resistance in glioblastoma.

  • Authors : Cheng YL; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.; Banu MA

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/pathology ; Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Glioblastoma*/Glioblastoma*/Glioblastoma*/metabolism

  • Source: Cell reports [Cell Rep] 2024 May 28; Vol. 43 (5), pp. 114139. Date of Electronic Publication: 2024 Apr 21.Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

C5aR1 inhibition reprograms tumor associated macrophages and reverses PARP inhibitor resistance in breast cancer.

  • Authors : Li X; Division of Oncological Sciences Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. .; Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. .

Subjects: Poly(ADP-ribose) Polymerase Inhibitors*/Poly(ADP-ribose) Polymerase Inhibitors*/Poly(ADP-ribose) Polymerase Inhibitors*/pharmacology ; Poly(ADP-ribose) Polymerase Inhibitors*/Poly(ADP-ribose) Polymerase Inhibitors*/Poly(ADP-ribose) Polymerase Inhibitors*/therapeutic use ; Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/genetics

  • Source: Nature communications [Nat Commun] 2024 May 27; Vol. 15 (1), pp. 4485. Date of Electronic Publication: 2024 May 27.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors.

  • Authors : Sui F; Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, 710061, P.R. China.; Department of Otorhinolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, 710061, P.R. China.

Subjects: Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/genetics ; Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/antagonists & inhibitors ; Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/Proto-Oncogene Proteins B-raf*/metabolism

  • Source: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2024 May 25; Vol. 81 (1), pp. 238. Date of Electronic Publication: 2024 May 25.Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071

Record details

Read More Add to Saved list
×
  • 1-10 of  61,018 results for ""Drug Resistance, Neoplasm""